Cargando…
Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518070/ https://www.ncbi.nlm.nih.gov/pubmed/27872948 http://dx.doi.org/10.1007/s00125-016-4146-6 |
Ejemplares similares
-
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
por: Solomon, Sharon D., et al.
Publicado: (2017) -
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
por: Pop-Busui, Rodica, et al.
Publicado: (2017) -
Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association
por: Chiang, Jane L., et al.
Publicado: (2018) -
Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
por: Chiang, Jane L., et al.
Publicado: (2014) -
Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association
por: Arslanian, Silva, et al.
Publicado: (2018)